Literature DB >> 2498394

pp60c-src activation in human colon carcinoma.

C A Cartwright1, M P Kamps, A I Meisler, J M Pipas, W Eckhart.   

Abstract

We measured the in vitro protein-tyrosine kinase activity of pp60c-src from human colon carcinoma cell lines and tumors. The activity of pp60c-src from six of nine carcinoma cell lines was higher (on average, fivefold as measured by enolase phosphorylation, or eightfold as measured by autophosphorylation) than that of pp60c-src from normal colonic mucosal cells, or human or rodent fibroblasts. Similarly, the activity of pp60c-src from 13 of 21 primary colon carcinomas was five- or sevenfold higher than that of pp60c-src from normal colonic mucosa adjacent to the tumor. The increased pp60c-src activity did not result solely from an increase in the level of pp60c-src protein, suggesting the specific activity of the pp60c-src kinase is elevated in the tumor cells. pp60c-src from colon carcinoma cells and normal colonic mucosal cells was phosphorylated at similar sites. We used immunoblotting with antibodies to phosphotyrosine to identify substrates of protein-tyrosine kinases in colonic cells. Three phosphotyrosine-containing proteins were detected at significantly higher levels in most colon carcinoma cell lines than in normal colonic mucosal cells or human or rat fibroblasts. All colon carcinoma cell lines with elevated pp60c-src in vitro kinase activity, showed increased phosphorylation of proteins on tyrosine in vivo, suggesting the presence of an activated protein-tyrosine kinase(s).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498394      PMCID: PMC303927          DOI: 10.1172/JCI114113

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor.

Authors:  R Ralston; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

2.  Structural and functional modification of pp60c-src associated with polyoma middle tumor antigen from infected or transformed cells.

Authors:  C A Cartwright; M A Hutchinson; W Eckhart
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

3.  Polyomavirus middle T protein encoded by a retrovirus transforms nonestablished chicken embryo cells.

Authors:  P L Kaplan; S Simon; W Eckhart
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

4.  Expression of c-myc and other cell cycle-dependent genes in human colon neoplasia.

Authors:  B Calabretta; L Kaczmarek; P M Ming; F Au; S C Ming
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

5.  A method to detect and characterize point mutations in transcribed genes: amplification and overexpression of the mutant c-Ki-ras allele in human tumor cells.

Authors:  E Winter; F Yamamoto; C Almoguera; M Perucho
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation.

Authors:  J Yokota; Y Tsunetsugu-Yokota; H Battifora; C Le Fevre; M J Cline
Journal:  Science       Date:  1986-01-17       Impact factor: 47.728

7.  Increased pp60c-src tyrosyl kinase activity in human neuroblastomas is associated with amino-terminal tyrosine phosphorylation of the src gene product.

Authors:  J B Bolen; N Rosen; M A Israel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

8.  Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation.

Authors:  S A Courtneidge
Journal:  EMBO J       Date:  1985-06       Impact factor: 11.598

9.  Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma.

Authors:  P G Rothberg; J M Spandorfer; M D Erisman; R N Staroscik; H F Sears; R O Petersen; S M Astrin
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

10.  Detection of the c-myc oncogene product in colonic polyps and carcinomas.

Authors:  J Stewart; G Evan; J Watson; K Sikora
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

View more
  69 in total

1.  Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling.

Authors:  Emma Sandilands; Bryan Serrels; David G McEwan; Jennifer P Morton; Juan Pablo Macagno; Kenneth McLeod; Craig Stevens; Valerie G Brunton; Wallace Y Langdon; Marcos Vidal; Owen J Sansom; Ivan Dikic; Simon Wilkinson; Margaret C Frame
Journal:  Nat Cell Biol       Date:  2011-12-04       Impact factor: 28.824

Review 2.  Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement: insights from in vivo imaging.

Authors:  Alan Serrels; Marta Canel; Valerie G Brunton; Margaret C Frame
Journal:  Cell Adh Migr       Date:  2011-07-01       Impact factor: 3.405

3.  The molecular genetics of colorectal carcinoma--knowledge for knowledge's sake?

Authors:  S R Hamilton
Journal:  West J Med       Date:  1991-06

4.  Pervanadate stabilizes desmosomes.

Authors:  David R Garrod; Christal Fisher; Angela Smith; Zhuxiang Nie
Journal:  Cell Adh Migr       Date:  2008-07-03       Impact factor: 3.405

5.  RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cells.

Authors:  B Y Chang; K B Conroy; E M Machleder; C A Cartwright
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

6.  Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.

Authors:  H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

7.  Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers.

Authors:  M C Maa; T H Leu; D J McCarley; R C Schatzman; S J Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

8.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

Review 9.  Protein kinases in human breast cancer.

Authors:  W G Cance; E T Liu
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

10.  Drosophila C-terminal Src kinase negatively regulates organ growth and cell proliferation through inhibition of the Src, Jun N-terminal kinase, and STAT pathways.

Authors:  Renee D Read; Erika A Bach; Ross L Cagan
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.